-
-
Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2),, 50 микрограмм
-
Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A),, 50 микрограмм
-
Anti-CLEC4C Reference Antibody (BIIB059),, 50 микрограмм
-
Anti-CLEC12A / CD371 Reference Antibody (tepoditamab),, 50 микрограмм
-
Anti-CLDN18.2 Reference Antibody (zolbetuximab),, 50 микрограмм
-
Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1),, 50 микрограмм
-
Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain),, 50 микрограмм
-
Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab),, 50 микрограмм
-
Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab),, 50 микрограмм
-
Anti-CEACAM6 / CD66c Reference Antibody (NEO-201),, 50 микрограмм
-
Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab),, 50 микрограмм
стр.: